Learn More
Medchemexpress LLC Tranylcypromine (hydrochloride) | 1986-47-6 | 99.9% | 169.66 | 500 MG

Supplier: Medchemexpress LLC HY17447A500MG
Tranylcypromine hydrochloride is an irreversible inhibitor of lysine-specific demethylase 1 (LSD1/BHC110) and monoamine oxidase (MAO). It inhibits LSD1, MAO A, and MAO B with IC50s of 20.7, 2.3, and 0.95 μM, respectively. This compound can be used for research related to depression.
- Irreversible inhibitor of LSD1/BHC110 and MAO.
- Inhibits MAO-A with an IC50 of 2.3 μM.
- Inhibits MAO-B with an IC50 of 0.95 μM.
- Inhibits LSD1 with an IC50 of 20.7 μM.
- Potential use in depression research.
- Inhibits histone and nucleosomal demethylation.
- Shows specific derepression of OCT4 transcription.
- Decreases LPS-mediated microglial activation and proinflammatory cytokine COX-2 and IL-6 levels in wild-type mice.
- Down-regulates Aβ-mediated microglial activation in 5xFAD mice.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.